• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

施复捷及相关药物对从败血症和心内膜炎病例中分离出的口腔链球菌的体外活性。

In-vitro activity of synercid and related drugs against Streptococcus oralis isolated from septicaemia and endocarditis cases.

作者信息

Rafay A M

机构信息

Department of Microbiology, College of Medicine, Sultan Qaboos University, P.O.Box: 35, Postal Code: 123, Muscat, Sultanate of Oman.

出版信息

J Sci Res Med Sci. 2000 Jan;2(1):25-31.

PMID:24019702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3174699/
Abstract

OBJECTIVE

The increase in resistance to gram positive organisms and seriousness of infective endocarditis, makes it necessary to look for an alternate treatment.

METHOD

In-vitro activity of synercid was compared with penicillin, amoxycillin, teicoplanin, vancomycin, clindamycin and erythromycin.

RESULT

Synercid showed minimum inhibitory concentrations (MIC) within the narrow range of 0.06 - 0.5 mg/l. MIC50 and mode values were both 0.25 mg/l. There was just two-fold difference between the MIC50 (0.25 mg/l) and the MIC90, (0.5 mg/l). Although the MICs of synercid for S. oralis were relatively high compared to penicillin, clindamycin, erythromycin and teicoplanin, the in-vitro bactericidal activity of synercid was much greater. Synercid MBC values were < 4 mg/l for most of the isolates, except for one of 16 mg/l and the other >64 mg/l. Killing curve was performed on six isolates of S. oralis from infective endocarditis, two from septicaemia patients and two from the oral flora of normal individuals.

CONCLUSION

Synercid showed superior bactericidal activity when compared to penicillin and vancomycin against all ten isolates of S. oralis tested. Synercid was bactericidal (99.9% kill) against all ten isolates of S. oralis within six hours of contact.

摘要

目的

革兰氏阳性菌耐药性的增加以及感染性心内膜炎的严重性,使得有必要寻找替代治疗方法。

方法

将速溶链霉素的体外活性与青霉素、阿莫西林、替考拉宁、万古霉素、克林霉素和红霉素进行比较。

结果

速溶链霉素的最低抑菌浓度(MIC)在0.06 - 0.5毫克/升的窄范围内。MIC50和众数均为0.25毫克/升。MIC50(0.25毫克/升)和MIC90(0.5毫克/升)之间只有两倍的差异。尽管与青霉素、克林霉素、红霉素和替考拉宁相比,速溶链霉素对口腔链球菌的MIC相对较高,但其体外杀菌活性要大得多。除了一株为16毫克/升和另一株>64毫克/升外,大多数分离株的速溶链霉素MBC值<4毫克/升。对来自感染性心内膜炎的6株口腔链球菌、2株败血症患者和2株正常个体口腔菌群的分离株进行了杀菌曲线测定。

结论

与青霉素和万古霉素相比,速溶链霉素对所有10株测试的口腔链球菌均显示出优异的杀菌活性。速溶链霉素在接触6小时内对所有10株口腔链球菌均具有杀菌作用(杀灭率99.9%)。

相似文献

1
In-vitro activity of synercid and related drugs against Streptococcus oralis isolated from septicaemia and endocarditis cases.施复捷及相关药物对从败血症和心内膜炎病例中分离出的口腔链球菌的体外活性。
J Sci Res Med Sci. 2000 Jan;2(1):25-31.
2
Comparative in-vitro activity of trovafloxacin and other related drugs against isolates of streptococcus oralis.
Saudi Med J. 2001 Mar;22(3):238-43.
3
In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.肺炎链球菌菌株对九种β-内酰胺类抗生素的体外敏感性以及头孢菌素单独使用及与万古霉素或庆大霉素联合使用时的杀菌动力学。
Microb Drug Resist. 1996 Fall;2(3):361-9. doi: 10.1089/mdr.1996.2.361.
4
The bactericidal activity of vancomycin and teicoplanin against Streptococcus pneumoniae.
Scand J Infect Dis Suppl. 1990;72:20-5.
5
Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).亚太地区革兰氏阳性菌分离株的抗菌药敏性以及达托霉素、万古霉素和替考拉宁杀菌活性的体外评估:哨兵计划报告(2003 - 2004年)
Int J Antimicrob Agents. 2007 Aug;30(2):143-9. doi: 10.1016/j.ijantimicag.2007.03.015. Epub 2007 May 24.
6
In vitro activity and post-antibiotic effect of quinupristin/dalfopristin (Synercid).奎奴普丁/达福普汀(Synercid)的体外活性及抗生素后效应
Chemotherapy. 2001 Jul-Aug;47(4):243-9. doi: 10.1159/000048530.
7
Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology.采用时间杀菌法对青霉素G、RP 59500、红霉素、司帕沙星、环丙沙星和万古霉素的抗肺炎球菌活性进行比较研究。
Antimicrob Agents Chemother. 1994 Sep;38(9):2065-72. doi: 10.1128/AAC.38.9.2065.
8
Activity of teicoplanin compared with vancomycin alone, and combined with gentamicin, against penicillin tolerant viridans streptococci and enterococci causing endocarditis.替考拉宁与单独使用万古霉素以及与庆大霉素联合使用时,对引起心内膜炎的耐青霉素草绿色链球菌和肠球菌的活性比较。
J Hosp Infect. 1986 Mar;7 Suppl A:65-72. doi: 10.1016/0195-6701(86)90009-5.
9
A comparative study of the in-vitro activity of levofloxacin against Streptococcus pneumoniae.左氧氟沙星对肺炎链球菌体外活性的比较研究
J Antimicrob Chemother. 1999 Jun;43 Suppl C:5-8. doi: 10.1093/jac/43.suppl_3.5.
10
In vitro susceptibilities of 176 clinical isolates of Streptococcus pneumoniae to 11 beta-lactams, erythromycin, and tetracycline.176株肺炎链球菌临床分离株对11种β-内酰胺类抗生素、红霉素和四环素的体外敏感性
Acta Clin Belg. 1996;51(6):377-85. doi: 10.1080/22953337.1996.11718535.

引用本文的文献

1
Characterization of high-level daptomycin resistance in Viridans group Streptococci developed upon in vitro exposure to daptomycin.在体外接触达托霉素后出现的草绿色链球菌中高水平达托霉素耐药性的特征分析。
Antimicrob Agents Chemother. 2015 Apr;59(4):2102-12. doi: 10.1128/AAC.04219-14. Epub 2015 Jan 26.

本文引用的文献

1
The estimation of the bactericidal power of the blood.血液杀菌能力的评估。
J Hyg (Lond). 1938 Nov;38(6):732-49. doi: 10.1017/s002217240001158x.
2
Gram-positive resistance: challenge for the development of new antibiotics.革兰氏阳性菌耐药性:新型抗生素研发面临的挑战
J Antimicrob Chemother. 1997 May;39 Suppl A:1-6. doi: 10.1093/jac/39.suppl_1.1.
3
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.对万古霉素敏感性降低的耐甲氧西林金黄色葡萄球菌临床菌株。
J Antimicrob Chemother. 1997 Jul;40(1):135-6. doi: 10.1093/jac/40.1.135.
4
Identity of viridans streptococci isolated from cases of infective endocarditis.从感染性心内膜炎病例中分离出的草绿色链球菌的鉴定。
J Med Microbiol. 1993 Sep;39(3):179-82. doi: 10.1099/00222615-39-3-179.
5
Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology.采用时间杀菌法对青霉素G、RP 59500、红霉素、司帕沙星、环丙沙星和万古霉素的抗肺炎球菌活性进行比较研究。
Antimicrob Agents Chemother. 1994 Sep;38(9):2065-72. doi: 10.1128/AAC.38.9.2065.
6
The microbiology and pathogenesis of infective endocarditis.感染性心内膜炎的微生物学及发病机制
Br Heart J. 1983 Dec;50(6):513-9. doi: 10.1136/hrt.50.6.513.
7
Infective endocarditis: incidence and mortality in the North East Thames Region.感染性心内膜炎:泰晤士河北部地区的发病率和死亡率
Br Heart J. 1988 Jan;59(1):62-8. doi: 10.1136/hrt.59.1.62.
8
Aetiology and epidemiology of infective endocarditis in England and Wales.英格兰和威尔士感染性心内膜炎的病因学与流行病学
J Antimicrob Chemother. 1987 Sep;20 Suppl A:7-15. doi: 10.1093/jac/20.suppl_a.7.
9
In-vitro susceptibility of oral streptococci to pristinamycin.
J Antimicrob Chemother. 1987 May;19(5):585-90. doi: 10.1093/jac/19.5.585.
10
Coagulase-negative staphylococci. Epidemiology, evaluation, and therapy.凝固酶阴性葡萄球菌。流行病学、评估与治疗。
Infect Dis Clin North Am. 1989 Dec;3(4):915-29.